Site name unknown, London NW1 2PG

Site:	Site name unknown, London NW1 2PG
Address:
City:	London
State:
Zip:	NW1 2PG
Country:	UK

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors (Resistant at 400 mg Imatinib)	Terminated	Closed	Sunitinib or Imatinib	NCT00372567